StockData
Senti Biosciences Holdings, Inc. logo

Senti Biosciences Holdings, Inc. (SNTI) stock

SNTINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.10−0.04 (-28.68%)

Close on Nov 17, 2026Market cap $3.02MP/E –Yield –

Senti Biosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Senti Biosciences's profit margin for the twelve months ending Jun 30, 2024 was -32335.8%. For fiscal 2025 it was -279263.6%, against -2774.6% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-279263.6%−276489.0
FY2023Dec 31, 2023-2774.6%−1416.5
FY2022Dec 31, 2022-1358.1%+645.4
FY2021Dec 31, 2021-2003.6%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-75000.0%−73544.2
Q1 FY2026Mar 31, 2026-26381.3%+72279.8
Q3 FY2023Sep 30, 2023-4415.1%−3472.8
Q2 FY2023Jun 30, 2023-1995.4%−1144.7
Q1 FY2023Mar 31, 2023-1455.8%−386.3
Q4 FY2022Dec 31, 2022-98661.0%−97286.0
Q3 FY2022Sep 30, 2022-942.2%+91.8
Q2 FY2022Jun 30, 2022-850.7%+663.5
Q1 FY2022Mar 31, 2022-1069.6%–
Q4 FY2021Dec 31, 2021-1375.0%–
Q3 FY2021Sep 30, 2021-1034.1%–
Q2 FY2021Jun 30, 2021-1514.1%–

More Senti Biosciences figures

See a number that looks wrong?